The results of the Crit-CoV-U study with 1,017 patients are available and confirm the results of the interims study that led to the special approval by the German Federal Institute for Drugs and Medical Devices (BfArM). The interims study with 327 patients was already published under Crit-CoV-U in the scientific journal LANCET EClinicalMedicine on May 2, 2021: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00163-2/fulltext